Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance

Background. Pancreatic tumors are rare and could arise from either the exocrine (ductal and acinar cells) or the endocrine (neuroendocrine cells) components of the pancreas. In some instances, the occurrence of pancreatic tumors comprising both acinar cells and neuroendocrine cells, with neuroendoc...

Full description

Bibliographic Details
Main Authors: Ogbonna, Onyekachi Henry, Garcon, Marie Carmel, Syrigos, Kostas N., Saif, Muhammad Wasif
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855931/
id pubmed-3855931
recordtype oai_dc
spelling pubmed-38559312013-12-17 Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance Ogbonna, Onyekachi Henry Garcon, Marie Carmel Syrigos, Kostas N. Saif, Muhammad Wasif Case Report Background. Pancreatic tumors are rare and could arise from either the exocrine (ductal and acinar cells) or the endocrine (neuroendocrine cells) components of the pancreas. In some instances, the occurrence of pancreatic tumors comprising both acinar cells and neuroendocrine cells, with neuroendocrine cells making up more than 30% of the tumor, has been identified. This unique entity has been referred to as mixed acinar-neuroendocrine carcinoma (MANEC). Only about 20 such cases have been reported in the literature. Case Report. We report an interesting case of MANEC with neuroendocrine cell predominance in a woman presenting with epigastric pain secondary to a pancreatic mass with acinar and endocrine differentiation. She underwent surgical resection of the tumor and was offered adjuvant treatment chemotherapy with carboplatin, etoposide, and radiotherapy for positive tumor resection margins. Conclusions. Given the paucity of the cases of MANEC, continuous reporting of these cases when identified should be encouraged to aid oncologists in understanding the disease and help establish standardized management. Hindawi Publishing Corporation 2013 2013-11-17 /pmc/articles/PMC3855931/ /pubmed/24348574 http://dx.doi.org/10.1155/2013/705092 Text en Copyright © 2013 Onyekachi Henry Ogbonna et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Ogbonna, Onyekachi Henry
Garcon, Marie Carmel
Syrigos, Kostas N.
Saif, Muhammad Wasif
spellingShingle Ogbonna, Onyekachi Henry
Garcon, Marie Carmel
Syrigos, Kostas N.
Saif, Muhammad Wasif
Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
author_facet Ogbonna, Onyekachi Henry
Garcon, Marie Carmel
Syrigos, Kostas N.
Saif, Muhammad Wasif
author_sort Ogbonna, Onyekachi Henry
title Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
title_short Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
title_full Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
title_fullStr Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
title_full_unstemmed Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
title_sort mixed acinar-neuroendocrine carcinoma of the pancreas with neuroendocrine predominance
description Background. Pancreatic tumors are rare and could arise from either the exocrine (ductal and acinar cells) or the endocrine (neuroendocrine cells) components of the pancreas. In some instances, the occurrence of pancreatic tumors comprising both acinar cells and neuroendocrine cells, with neuroendocrine cells making up more than 30% of the tumor, has been identified. This unique entity has been referred to as mixed acinar-neuroendocrine carcinoma (MANEC). Only about 20 such cases have been reported in the literature. Case Report. We report an interesting case of MANEC with neuroendocrine cell predominance in a woman presenting with epigastric pain secondary to a pancreatic mass with acinar and endocrine differentiation. She underwent surgical resection of the tumor and was offered adjuvant treatment chemotherapy with carboplatin, etoposide, and radiotherapy for positive tumor resection margins. Conclusions. Given the paucity of the cases of MANEC, continuous reporting of these cases when identified should be encouraged to aid oncologists in understanding the disease and help establish standardized management.
publisher Hindawi Publishing Corporation
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855931/
_version_ 1612036344440160256